Stereotactic body radiation therapy with androgen deprivation therapy for unfavorable-risk prostate cancer.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2020.38.6_suppl.332
Abstract: 332Background: Current ASTRO consensus guidelines do not support routine use of SBRT in higher risk PC. However, the NCCN permits selective use of SBRT with ADT for unfavorable intermediate (UIR) a... read more here.
Keywords: risk; radiation therapy; therapy androgen; body radiation ... See more keywords
Combination therapy with androgen receptor pathway inhibitors for prostate cancer.
Sign Up to like & getrecommendations! Published in 2023 at "Current cancer drug targets"
DOI: 10.2174/1568009623666230220121610
Abstract: read more here.
Keywords: receptor pathway; androgen receptor; pathway inhibitors; combination therapy ... See more keywords